ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 169 filers reported holding ALLAKOS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $237,000 | +24.1% | 2,242 | 0.0% | 0.04% | +40.0% |
| Q2 2021 | $191,000 | -25.7% | 2,242 | 0.0% | 0.03% | -31.8% |
| Q1 2021 | $257,000 | -18.2% | 2,242 | 0.0% | 0.04% | -18.5% |
| Q4 2020 | $314,000 | +71.6% | 2,242 | 0.0% | 0.05% | +58.8% |
| Q3 2020 | $183,000 | +13.7% | 2,242 | 0.0% | 0.03% | +17.2% |
| Q2 2020 | $161,000 | +61.0% | 2,242 | 0.0% | 0.03% | +31.8% |
| Q1 2020 | $100,000 | -53.3% | 2,242 | 0.0% | 0.02% | -43.6% |
| Q4 2019 | $214,000 | – | 2,242 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $561,037,000 | 86.41% |
| Fairmount Funds Management LLC | 147,662 | $16,949,000 | 7.14% |
| NEA Management Company, LLC | 2,164,704 | $248,465,000 | 5.58% |
| Redmile Group, LLC | 2,419,418 | $277,701,000 | 3.91% |
| Samsara BioCapital, LLC | 146,259 | $16,788,000 | 3.10% |
| Samsara BioCapital, LLC | 83,000 | $9,527,000 | 1.76% |
| Rock Springs Capital Management LP | 305,706 | $35,089,000 | 0.77% |
| Tekla Capital Management LLC | 163,645 | $18,783,000 | 0.65% |
| Legal Advantage Investments, Inc. | 7,000 | $803,000 | 0.60% |
| Eventide Asset Management | 317,000 | $36,385,000 | 0.54% |